Genome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy

BACKGROUND: Molecular analysis is a promising source of clinically useful prognostic biomarkers. The aim of this investigation was to identify prognostic biomarkers for patients with early-stage pancreatic ductal adenocarcinoma (PDAC) after pancreaticoduodenectomy. METHODS: An RNA sequencing dataset...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Xiwen, Huang, Ketuan, Huang, Rui, Liu, Xiaoguang, Han, Chuangye, Yu, Long, Yu, Tingdong, Yang, Chengkun, Wang, Xiangkun, Peng, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602474/
https://www.ncbi.nlm.nih.gov/pubmed/28979141
http://dx.doi.org/10.2147/OTT.S142557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602474/
https://www.ncbi.nlm.nih.gov/pubmed/28979141
http://dx.doi.org/10.2147/OTT.S142557

Ejemplares similares